🇺🇸 FDA
Patent

US 11304988

Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C)

granted A61KA61K38/08A61P

Quick answer

US patent 11304988 (Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C)) held by Northwestern University expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/08, A61P, A61P35/04